DPD-based adaptive dosing of 5-FU in patients with head and neck cancer: impact on treatment efficacy and toxicity. [electronic resource]
Producer: 20110131Description: 49-56 p. digitalISSN:- 1432-0843
- Adult
- Aged
- Aged, 80 and over
- Antimetabolites, Antineoplastic -- administration & dosage
- Dihydropyrimidine Dehydrogenase Deficiency -- genetics
- Dihydrouracil Dehydrogenase (NADP) -- genetics
- Dose-Response Relationship, Drug
- Female
- Fluorouracil -- administration & dosage
- Head and Neck Neoplasms -- drug therapy
- Humans
- Male
- Middle Aged
- Pharmacogenetics
- Prospective Studies
- Retrospective Studies
- Severity of Illness Index
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.